IOL Chemicals & Pharmaceuticals Ltd: Breakout in Sight?

IOLCP is showing early signs of a technical breakout — supported by both price action and business fundamentals. Let’s take a closer look: 📊 Technical Snapshot ✅ Current Price: ₹94.10 (+6.04% this week) ✅ Breakout from falling trendline (~₹80 zone) ✅ Approaching key resistance zone ₹100–₹104 ✅ Forming higher lows — bullish structure ✅ Rising volume confirms buyer interest ⚙️ Support & Resistance Level Zone Resistance ₹100–₹104 Support ₹90, ₹72 🎯 Business Tailwinds (Recent Positives) 🏭 New Paracetamol Unit (10,800 MTPA) commissioned in Mar 2025 💊 Clopidogrel capacity up 33% — strong cardiovascular API demand 🌏 Ibuprofen approval for China — new export market unlocked 📈 Non-Ibuprofen APIs now 34% of API revenue (up from 18% in 5 yrs) 📈 Management targets 40–45% export revenue in next 2 years 💸 Strong cash PAT ₹185 Cr & low leverage (Net D/E 0.09) 🏗️ 101 acres acquired for future expansion 🚀 Outlook Breakout above ₹104 could open the path toward ₹115+. Strong fundamentals support the technical bullish bias: Backward integration driving cost efficiency. Diversified API portfolio reducing dependence on Ibuprofen. Healthy capex pipeline for growth. Monitor for a sustained close above ₹104 on weekly chart → potential confirmation of breakout. 📢 Disclaimer: This is for informational purposes only. Nothing herein constitutes a buy or sell recommendation. I may or may not be holding a position in the stock mentioned. 🧑‍💼 Rajneesh Sharma is a SEBI-registered Research Analyst (Reg. No. INH000020332). 📄 Investments are subject to market risks. Read all related documents carefully before investing.